Integrase inhibitors effective against human T-cell leukemia virus type 1

Keyphrases

• Human T-cell Leukemia Virus Type 1 (HTLV-1) 100%
• Integrase Inhibitors 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 33%
• Viral Integration 33%
• Raltegravir 33%
• Cell-to-cell 16%
• Peripheral Blood Mononuclear Cells 16%
• Drug Target 16%
• Treatment Regimen 16%
• Integrase 16%
• Adaptation 16%
• Associated Diseases 16%
• Cell-free 16%
• Reverse Transcription 16%
• Immortalization 16%
• Cell-to-cell Transmission 16%
• Acid Derivatives 16%
• Viral Enzymes 16%
• Similarity Classes 16%
• Diketo Acid 16%
• MK-2048 16%

Immunology and Microbiology

• Human T-Lymphotropic Virus 1 100%
• Integrase 100%
• Human Immunodeficiency Virus 1 33%
• In Vitro 33%
• Reverse Transcription 16%
• Drug Targeting 16%
• Viral Enzymes 16%
• Peripheral Blood Mononuclear Cell 16%
• Infection 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Human T-Lymphotropic Virus 1 100%
• Integrase Inhibitor 100%
• Raltegravir 33%
• Human Immunodeficiency Virus 1 33%
• Infection 16%
• Drug Delivery System 16%
• Integrase 16%
• Diseases 16%